-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Merck & Co, Raises Price Target to $175

Benzinga·08/20/2026 15:53:24
Listen to the news
UBS analyst Michael Yee maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $145 to $175.